DE69810498T2 - Ace-inhibitoren stickstoffsalze - Google Patents

Ace-inhibitoren stickstoffsalze

Info

Publication number
DE69810498T2
DE69810498T2 DE69810498T DE69810498T DE69810498T2 DE 69810498 T2 DE69810498 T2 DE 69810498T2 DE 69810498 T DE69810498 T DE 69810498T DE 69810498 T DE69810498 T DE 69810498T DE 69810498 T2 DE69810498 T2 DE 69810498T2
Authority
DE
Germany
Prior art keywords
ace inhibitors
nitrogen salt
nitrogen
salt
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69810498T
Other languages
English (en)
Other versions
DE69810498D1 (de
Inventor
Soldato Piero Del
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nicox SA
Original Assignee
Nicox SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox SA filed Critical Nicox SA
Publication of DE69810498D1 publication Critical patent/DE69810498D1/de
Application granted granted Critical
Publication of DE69810498T2 publication Critical patent/DE69810498T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0217—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -C(=O)-C-N-C(=O)-N-C-C(=O)-
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
DE69810498T 1997-06-27 1998-06-24 Ace-inhibitoren stickstoffsalze Expired - Fee Related DE69810498T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI001523A IT1292426B1 (it) 1997-06-27 1997-06-27 Sali nitrati di ace-inibitori
PCT/EP1998/003946 WO1999000361A1 (en) 1997-06-27 1998-06-24 Ace-inhibitor nitric salts

Publications (2)

Publication Number Publication Date
DE69810498D1 DE69810498D1 (de) 2003-02-06
DE69810498T2 true DE69810498T2 (de) 2003-10-30

Family

ID=11377450

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69810498T Expired - Fee Related DE69810498T2 (de) 1997-06-27 1998-06-24 Ace-inhibitoren stickstoffsalze

Country Status (17)

Country Link
US (1) US6218417B1 (de)
EP (1) EP1019370B1 (de)
JP (1) JP2002506456A (de)
KR (1) KR100512892B1 (de)
CN (1) CN1205186C (de)
AT (1) ATE230393T1 (de)
AU (1) AU740411B2 (de)
BR (1) BR9810459A (de)
CA (1) CA2292794A1 (de)
DE (1) DE69810498T2 (de)
DK (1) DK1019370T3 (de)
ES (1) ES2190095T3 (de)
HU (1) HUP0003133A3 (de)
IL (1) IL132691A (de)
IT (1) IT1292426B1 (de)
RU (1) RU2194037C2 (de)
WO (1) WO1999000361A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1301759B1 (it) * 1998-06-19 2000-07-07 Nicox Sa Sali nitrati di farmaci antiipertensivi
IT1303672B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali nitrati di farmaci attivi nei disordini ossei
WO2001017528A1 (en) 1999-09-08 2001-03-15 Nitromed, Inc. Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
US7708989B2 (en) * 1999-10-29 2010-05-04 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
DE60042611D1 (de) 1999-10-29 2009-09-03 Nitromed Inc Verfahren zur behandlung von gefässerkrankungen, dxid auszeichnen
US7235237B2 (en) 1999-10-29 2007-06-26 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
US7537785B2 (en) 1999-10-29 2009-05-26 Nitromed, Inc. Composition for treating vascular diseases characterized by nitric oxide insufficiency
EP1406608B1 (de) 2001-05-02 2009-07-29 Nitromed, Inc. Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
US20080026984A1 (en) * 2002-02-04 2008-01-31 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
US7968605B2 (en) * 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
EP2319518A1 (de) * 2002-02-04 2011-05-11 ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. Verwendung CO-freisetzender Verbindungen zur Behandlung entzündlicher Erkrankungen
US20060247216A1 (en) * 2002-10-25 2006-11-02 Haj-Yehia Abdullah I Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
US20070207217A1 (en) * 2003-02-03 2007-09-06 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO
US7169805B2 (en) * 2003-05-28 2007-01-30 Nicox S.A. Captopril derivatives
JP2008506716A (ja) * 2004-07-16 2008-03-06 ニトロメッド インコーポレーティッド 心不全に関連する組成物および方法
DE602005020314D1 (de) 2004-08-25 2010-05-12 Actelion Pharmaceuticals Ltd Bicyclononen-derivate als renin-inhibitoren
EP1679072B9 (de) * 2005-01-06 2009-09-02 IPCA Laboratories Limited Verfahren zur Synthese von (2S,3aS,7aS)-1-(S)-Alanyl-octahydro-1H-2-carbonsäurederivaten und Verwendung in der Synthese von Perindopril
WO2006121853A1 (en) * 2005-05-05 2006-11-16 Keryx Biopharmaceuticals, Inc. Combination therapy with sulodexide and a blood pressure reducing agent in the treatment of diabetic nephropathy
EP1893578A2 (de) * 2005-05-27 2008-03-05 Actelion Pharmaceuticals Ltd. Neuartige piperidincarboxylsäureamid-derivate
JP2009514809A (ja) * 2005-10-18 2009-04-09 ニコックス エス エイ レニン阻害剤のニトロ誘導体
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
AU2007210813A1 (en) 2006-02-02 2007-08-09 Actelion Pharmaceuticals Ltd Secondary amines as renin inhibitors
EP1984010A4 (de) * 2006-02-17 2010-09-08 Nitromed Inc Verfahren zur verwendung von hydralazinverbindungen und isosorbiddinitrat oder isosorbidmononitrat
JP2009529033A (ja) * 2006-03-08 2009-08-13 アクテリオン ファーマシューティカルズ リミテッド 新規アミン
WO2007136626A1 (en) * 2006-05-16 2007-11-29 Nitromed, Inc. Solid dosage formulations of hydralazine compounds
CN102015682B (zh) 2008-05-05 2014-07-16 埃科特莱茵药品有限公司 作为肾素抑制剂的3,4-取代的哌啶衍生物
ES2656237T3 (es) 2011-04-19 2018-02-26 Alfama, Inc. Moléculas liberadoras de monóxido de carbono y usos de las mismas
WO2013013179A1 (en) 2011-07-21 2013-01-24 Alfama, Inc. Ruthenium carbon monoxide releasing molecules and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE463851B (sv) 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
US5352708A (en) 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5328933A (en) 1992-10-28 1994-07-12 Allergan, Inc. Cyclopentane heptenylnitro and heptanylnitro-2-aliphatic or aryl aliphatic derivatives and homologues
KR100387359B1 (ko) 1994-05-10 2003-08-27 니콕스 에스. 에이. 항-염증성,비알러지성및항-혈전성을가지는니트로화합물들과그들의조성물들
US5625083A (en) 1995-06-02 1997-04-29 Bezuglov; Vladimir V. Dinitroglycerol esters of unsaturated fatty acids and prostaglandins
US5645839A (en) * 1995-06-07 1997-07-08 Trustees Of Boston University Combined use of angiotensin inhibitors and nitric oxide stimulators to treat fibrosis
CN1141771A (zh) * 1995-08-02 1997-02-05 贾力 巯-亚硝基化合物及其医学用途

Also Published As

Publication number Publication date
EP1019370B1 (de) 2003-01-02
RU2194037C2 (ru) 2002-12-10
EP1019370A1 (de) 2000-07-19
HUP0003133A2 (en) 2001-03-28
US6218417B1 (en) 2001-04-17
CN1260780A (zh) 2000-07-19
ITMI971523A1 (it) 1998-12-27
BR9810459A (pt) 2006-10-03
ATE230393T1 (de) 2003-01-15
KR20010013958A (ko) 2001-02-26
IL132691A0 (en) 2001-03-19
CA2292794A1 (en) 1999-01-07
ES2190095T3 (es) 2003-07-16
DE69810498D1 (de) 2003-02-06
IL132691A (en) 2004-06-01
ITMI971523A0 (de) 1997-06-27
CN1205186C (zh) 2005-06-08
DK1019370T3 (da) 2003-05-05
IT1292426B1 (it) 1999-02-08
AU8730098A (en) 1999-01-19
AU740411B2 (en) 2001-11-01
KR100512892B1 (ko) 2005-09-07
WO1999000361A1 (en) 1999-01-07
HUP0003133A3 (en) 2002-10-28
JP2002506456A (ja) 2002-02-26

Similar Documents

Publication Publication Date Title
DE69810498D1 (de) Ace-inhibitoren stickstoffsalze
NO962269D0 (no) Enzyminhibitorer
FI955467A0 (fi) Soluadheesion inhibiittoreina toimivia Sialyl Lex-analogeja
ID18142A (id) Inhibitor metaloprotease 1,4-heterosiklik
NO942064D0 (no) yminhibitorer
FI973360A0 (fi) Uusia dipeptidisiä amidiineja trombiininestäjiksi
DE19680255T1 (de) Inhibitoren der Enzymaktivität von Rotamase
NO20000464L (no) Acykliske metalloprotease-inhibitorer
NO20004550D0 (no) Enzyminhibitorer
ID24829A (id) Garam natrium omeprazola
NO996578D0 (no) Urokinase-inhibitorer
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
PT958287E (pt) Inibidores de sulfamida-metaloprotease
NO20003256L (no) ACE inhibitor-MMP inhibitor kombinasjoner
DE68904083T2 (de) Hmg-coa-reduktaseinhibitoren.
NO981850D0 (no) Nµringsmiddel med kalsiumtilsats
NO990896D0 (no) Bidentate metalloproteaseinhibitorer
DE68901091D1 (de) Hmg-coa-reduktaseinhibitoren.
DE69632435D1 (de) Inhibitor des Hepatozytwachstumsfaktoraktivators
FI973929A (fi) WOF inhibiittori
GB9214720D0 (en) Enzyme inhibitors
DE69631500D1 (de) Inhibitor des Hepatozytwachstumsfaktoraktivators
ZA949525B (en) Enzyme inhibitors
ZA938867B (en) Enzyme inhibitors
BR7300339U (pt) Disposição em saleiro

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee